secwatch / observer
8-K filed August 8, 2023, 7:59 PM ET ticker NHI CIK 0000877860
earnings confidence high sentiment negative materiality 0.75

NHI reports Q2 net income $0.92/share, cuts full-year Normalized FFO guidance

NATIONAL HEALTH INVESTORS INC

2023-Q2 EPS reported $1.71 revenue$160,264,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

NATIONAL HEALTH INVESTORS INC reported three and six months ended June 30, 2023 results: EPS Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.. Guidance reaffirmed.

Period
three and six months ended June 30, 2023
EPS
Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.
Guidance
reaffirmed
Result
reported results
Exact text from the filing
NHI Announces Second Quarter 2023 Results MURFREESBORO, Tenn. – (August 8, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2023.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NATIONAL HEALTH INVESTORS INC reported 2023 results: EPS Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42. Guidance lowered.

Period
2023
EPS
Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42
Guidance
lowered
Result
guidance update
Exact text from the filing
NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42 and is revising Normalized FAD to a range of $185.0 million - $186.8 million from $186.3 million - $188.9 million.
View on SEC.gov

Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR
accession 0000877860-23-000087
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.